| Literature DB >> 31415622 |
Cecily R Wood1, Mariah S Squire1, Natosha L Finley1, Richard C Page2, Luis A Actis1.
Abstract
The Acinetobacter baumannii BlsA photoreceptor has an N-terminal (NT) BLUF domain and a C-terminal (CT) amino acid sequence with no significant homology to characterized bacterial proteins. In this study, we tested the biological role of specific residues located in these BlsA regions. Site-directed mutagenesis, surface motility assays at 24°C and protein overexpression showed that residues Y7, Q51 and W92 are essential for not only light-regulated motility, but also BlsA's solubility when overexpressed in a heterologous host. In contrast, residues A29 and F32, the latter representing a difference when compared with other BLUF-containing photoreceptors, do not play a major role in BlsA's biological functions. Analysis of the CT region showed that the deletion of the last five BlsA residues has no significant effect on the protein's light-sensing and motility regulatory functions, but the deletion of the last 14 residues as well as K144E and K145E substitutions significantly alter light-regulated motility responses. In contrast to the NT mutants, these CT derivatives were overexpressed and purified to homogeneity to demonstrate that although these mutations do not significantly affect flavin binding and photocycling, they do affect BlsA's photodynamic properties. Notably, these mutations map within a potential fifth α-helical component that could play a role in predicted interactions between regulatory partners and BlsA, which could function as a monomer according to gel filtration data. All these observations indicate that although BlsA shares common structural and functional properties with unrelated photoreceptors, it also exhibits unique features that make it a distinct BLUF photoreceptor.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31415622 PMCID: PMC6695109 DOI: 10.1371/journal.pone.0220918
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains and plasmids used in this work.
| Strains/plasmids | Relevant characteristic(s) | Source/reference |
|---|---|---|
| Strains | ||
| ATCC 17978 (17978) | Wildtype clinical isolate | ATCC |
| OR | [ | |
| OR.V | OR harboring empty pMU368; KmR; ZeoR | This work |
| OR.W | OR harboring pMU1202; KmR; ZeoR | This work |
| OR.Y7A | OR harboring pMU1229; KmR; ZeoR | This work |
| OR.A29S | OR harboring pMU1222; KmR; ZeoR | This work |
| OR.F32N | OR harboring pMU1213; KmR; ZeoR | This work |
| OR.Q51A | OR harboring pMU1226; KmR; ZeoR | This work |
| OR.Y7A/Q51A | OR harboring pMU1243; KmR; ZeoR | This work |
| OR.W92A | OR harboring pMU1270; KmR; ZeoR | This work |
| OR.K144E | OR harboring pMU1276; KmR; ZeoR | This work |
| OR.K145E | OR harboring pMU1250; KmR; ZeoR | This work |
| OR.Δ121–135 | OR harboring pMU1236; KmR; ZeoR | This work |
| OR.Δ135–147 | OR harboring pMU1251; KmR; ZeoR | This work |
| OR.Δ143–156 | OR harboring pMU1235; KmR; ZeoR | This work |
| OR.Δ152–156 | OR harboring pMU1232; KmR; ZeoR | This work |
| DH5α | DNA recombinant methods | Life Technologies |
| Top10 | DNA recombinant methods | Life Technologies |
| BL21(DE3) | λDE3, T7 RNA polymerase | Life Technologies |
| XL10-Gold | DNA recombinant methods | Life Technologies |
| Plasmids | ||
| pET-15b | Protein overexpression vector; AmpR | Novagen |
| pMU1254 | pET-15b harboring | This work |
| pMU1255 | pET-15b harboring | This work |
| pMU1256 | pET-15b harboring | This work |
| pMU1257 | pET-15b harboring | This work |
| pMU1258 | pET-15b harboring | This work |
| pMU1259 | pET-15b harboring | This study |
| pMU1271 | pET-15b harboring | This work |
| pMU1264 | pET-15b harboring | This work |
| pMU1273 | pET-15b harboring | This work |
| pMU1282 | pET-15b harboring | This work |
| pMU1298 | pET-15b harboring | This work |
| pMU1299 | pET-15b harboring | This work |
| pMU368 | [ | |
| pMU1202 | pMU368 harboring | This work |
| pMU1213 | pMU368 harboring | This work |
| pMU1222 | pMU368 harboring | This work |
| pMU1226 | pMU368 harboring | This work |
| pMU1229 | pMU368 harboring | This work |
| pMU1232 | pMU368 harboring | This work |
| pMU1235 | pMU368 harboring | This work |
| pMU1236 | pMU368 harboring | This work |
| pMU1243 | pMU368 harboring | This work |
| pMU1250 | pMU368 harboring | This work |
| pMU1251 | pMU368 harboring | This work |
| pMU1270 | pMU368 harboring | This work |
| pMU1276 | pMU368 harboring | This work |
aAmpR, ampicillin resistance; KmR, kanamycin resistance; ZeoR, zeocin resistance.
Fig 1Comparative analysis of short BLUF-containing photoreceptors.
The amino acid sequence of the BlsA, SnfB, BlrB, Tll0078 and Slr1694 proteins from A. baumannii ATCC 17978, Stenotrophomonas sp. SKA14, Rhodobacter sphaeroides, Thermosynechoccus elongatus BP-1 and Synechocystis sp. PCC6803, respectively, were compared using MUSCLE. Asterisks identify conserved residues. BlsA predicted secondary structure components are represented by black arrows (β strands) and grey rectangles (α helices). BlsA’s secondary structure was predicted using the SABLE server. The black horizontal bar identifies BlsA’s BLUF domain residues. Black triangles and the corresponding numbers above them indicate site-directed amino acid changes. The boxed BlsA residues identify an additional α component (α5) predicted using Robetta. The boxed SnfB, BlrB, Tll0078 and Slr1694 residues identify their cognate α4 components. The black horizontal rectangles shown at the bottom of the figure represent locations of site-directed deletions.
Fig 2Structural model of BlsA and comparison to known blue light sensing domains.
(A) Model of BlsA built using Robetta. BlsA is drawn as a cartoon colored by spectrum from the N-terminus (blue) to C-terminus (red) with secondary structure elements labeled and FAD drawn as sticks. The zoomed inset (rotated ~90° about the x-axis) shows BlsA residues (sticks) N33, Q51 and D70 making electrostatic contacts (yellow dashes) with FAD. (B) The BlsA model is superimposed with the structure of the AppA BLUF domain in the light- (blue, PDB ID 1yrx) and dark- (purple, PDB ID 2iyg) adapted states and Tll0078 (green, PDB ID 1x0p). (C) A zoomed view of BlsA helix α5 from the Robetta model highlights the positions of K144 and K145. (D) Surface model of the Tll0078 α4 (left) compared with surface models of two predicted BlsA CT α helices (middle and right) drawn using Modeller9v8. Yellow (polar), red (negative), blue (positive), grey (nonpolar). Visible residues are labeled according to their position in the amino acid sequence of the cognate proteins.
Fig 3Light-regulated surface motility of 17978 cells producing native BlsA or derivatives generated by site-directed mutagenesis.
(A) Motility of OR BlsA-deficient cells transformed with a pMU368 derivative coding for the F32N (OR.F32N), Y7A (OR.Y7A), Q51A (OR.Q51A), Y7A/Q51A (OR.Y7A/Q51A) or W92A (OR.W92A) NT mutant proteins. (B) Motility of OR BlsA deficient cells transformed with a pMU368 derivative coding for the Δ152–156 (OR.Δ152–156), Δ143–156 (OR.Δ143–156), Δ135–147 (OR.Δ135–147), K144E (OR.K144E) or K145E (OR.K145E) CT mutant proteins. The motility responses of the 17978 parental strain (17978), the BlsA OR mutant (OR) and the OR mutant transformed with a pMU368 derivative coding for the wild type protein (OR.W) were used as controls. Surface motility was tested using SA plates incubated at 24°C under darkness or illumination. Horizontal bars identify statistically different values (P ≤ 0.01, **; P ≤ 0.001, ***; P ≤ 0.0001, ****) and error bars represent the standard error of each data set.
Fig 4Analyses of His-tagged BlsA.
(A) Absorption spectra of lBlsA and dBlsA. The UV-Vis light spectra were recorded using His-tagged BlsA purified by Ni-affinity chromatography and SEC. The purity of the protein sample used for spectral analyses was confirmed by SDS-PAGE using 4%-20% polyacrylamide gradient gels (inset). (B) Elution profile of lBlsA and dBlsA upon chromatography in a Superose 6 Increase 10/300 GL column. The inset shows the calibration curve constructed using the elution volume of the gel filtration standards cytochrome C (12.4 kDa), carbonic anhydrase (29 kDa), bovine albumin (66 kDa), alcohol dehydrogenase (150 kDa) and β-amylase (200 kDa). The black and blue triangles indicate the elution position of dBlsA and lBlsA, respectively. (C) HPLC analysis of heat-denatured BlsA supernatant. The retention times for FAD, FMN and Ribo are indicated in min.
Kinetic values for light-to-dark recovery of His-BlsA and derivatives generated by site-directed point and deletion mutations.
| Protein | Half-time—t1/2 (min) | Time constant—τ (min) |
|---|---|---|
| His-BlsA | 10.2 | 14.7 |
| His-BlsA.K144E | 5.2 | 7.4 |
| His-BlsA.K145E | 7.6 | 11.0 |
| His-BlsA.Δ152–156 | 8.6 | 12.4 |
| His-BlsA.Δ143–156 | 5.2 | 7.4 |
Fig 5Spectral analysis of purified His-tagged BlsA derivatives generated by site-directed deletion and point mutagenesis.
The UV-Vis light spectra were recorded using His-tagged BlsA derivatives purified by Ni-affinity chromatography and SEC. The purity of the protein samples used for spectral analyses was confirmed by SDS-PAGE using 4%-20% polyacrylamide gradient gels (insets).
Fig 6Effects of K144E and K145E mutations on the electrostatic surface of BlsA.
(A) Cartoon model of BlsA, built using Robetta, with the positions of the ⍺-carbons of K144 and K145 shown as spheres. The color bar indicates correspondence for the electrostatic surfaces shown in panels B-D between color and charge at ±3kT. Panels B, C and D show the surfaces for wild type BlsA and the K144E, K145E derivatives, respectively, colored by charge on the solvent exposed surfaces as calculated with the Adaptive Poisson-Boltzmann Solver (APBS) [38, 39].